Skip to content

Clinical trials

Phase 3 Kidney Failure, Chronic trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Failure, Chronic Phase: Phase 3 Country / region: Czechia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20091
20142
20181
20191
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cara Therapeutics, Inc.2
Affymax1
Astellas Pharma Europe B.V.1
Bristol-Myers Squibb1
Eli Lilly and Company1
Hansa Biopharma AB1
Heidelberg University1
Ineos Healthcare Limited1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Failure, Chronic10
Renal Insufficiency, Chronic6
Anemia2
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
Pruritus2
Atherosclerosis1
Cerebrovascular Disorders1
Coronary Artery Disease1
Death1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.